Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
30.83
+0.48 (1.58%)
At close: Jul 8, 2026, 4:00 PM EDT
30.00
-0.83 (-2.69%)
After-hours: Jul 8, 2026, 7:59 PM EDT

Parabilis Medicines Statistics

Total Valuation

PBLS has a market cap or net worth of $3.93 billion. The enterprise value is $3.65 billion.

Market Cap3.93B
Enterprise Value 3.65B

Important Dates

The next estimated earnings date is Tuesday, August 18, 2026, before market open.

Earnings Date Aug 18, 2026
Ex-Dividend Date n/a

Share Statistics

PBLS has 127.34 million shares outstanding.

Current Share Class 125.76M
Shares Outstanding 127.34M
Shares Change (YoY) n/a
Shares Change (QoQ) +1.61%
Owned by Insiders (%) 0.01%
Owned by Institutions (%) 25.04%
Float 96.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 16.07
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.12, with a Debt / Equity ratio of 0.22.

Current Ratio 6.12
Quick Ratio 6.07
Debt / Equity 0.22
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -110.33

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -47.32%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.45M
Employee Count145
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 51.04
Average Volume (20 Days) 1,173,086

Short Selling Information

The latest short interest is 1.12 million, so 0.88% of the outstanding shares have been sold short.

Short Interest 1.12M
Short Previous Month n/a
Short % of Shares Out 0.88%
Short % of Float 1.15%
Short Ratio (days to cover) 0.47

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -156.12M
Pretax Income -152.88M
Net Income -209.71M
EBITDA -153.67M
EBIT -156.12M
Earnings Per Share (EPS) -$67.09
Full Income Statement

Balance Sheet

The company has $329.04 million in cash and $53.15 million in debt, with a net cash position of $275.89 million or $2.17 per share.

Cash & Cash Equivalents 329.04M
Total Debt 53.15M
Net Cash 275.89M
Net Cash Per Share $2.17
Equity (Book Value) 244.22M
Book Value Per Share -174.15
Working Capital 277.83M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$138.76 million and capital expenditures -$601,000, giving a free cash flow of -$139.36 million.

Operating Cash Flow -138.76M
Capital Expenditures -601,000
Depreciation & Amortization 2.45M
Net Borrowing -6.85M
Free Cash Flow -139.36M
FCF Per Share -$1.09
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PBLS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -5.34%
FCF Yield -3.55%

Analyst Forecast

The average price target for PBLS is $41.75, which is 35.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $41.75
Price Target Difference 35.42%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1